February 19, 2021 Acad, Gov/Utilities Clinical Research/Diagn. Environ, Ag./Food & Bev Life Science Tools

Illumina and the University Hospital of Tübingen Evaluate Potential of Whole Genome Sequencing to Improve Diagnosis of Full Range of Genetic Diseases

TÜBINGEN, Germany–(BUSINESS WIRE)–February 19, 2021 — Illumina, Inc. (Nasdaq: ILMN) today announced an agreement with the Institute of Medical Genetics and Applied Genomics at the University Hospital of Tübingen to assess the value of whole-genome sequencing (WGS) as a first-line diagnostic test for patients with genetic diseases and familial cancer syndromes. Illumina will support the... Read more

February 18, 2021 Clinical Research/Diagn. Life Science Tools Product Launch

Agilent Announces Immunoassay Kit to Detect SARS-CoV-2 Antibodies

Kit marks first of multiple planned for 2021 aimed at COVID-19  SANTA CLARA, Calif., February 18, 2021  Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit intended for the qualitative detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or plasma. The kit, which... Read more

February 9, 2021 Clinical Research/Diagn. Lab Top-10 M&A, Partnerships

Thermo Fisher Scientific Partners with Mindray on Clinical Chemistry Analyzers for use with Drugs of Abuse Immunoassays

Thermo Fisher Scientific Partners with Mindray on Clinical Chemistry Analyzers for use with Drugs of Abuse Immunoassays FREMONT, Calif., Feb. 9, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced a partnership with Mindray, a leading global developer, manufacturer and supplier of medical devices, to make available to customers two... Read more

February 8, 2021 Clinical Research/Diagn. Lab Top-10 Liq. Handling & Robotics Product Launch

Thermo Fisher Scientific Launches CE-IVD-Marked High Throughput COVID-19 Diagnostic Assay for Use On Its Automated Amplitude Platform

Thermo Fisher Scientific Launches CE-IVD-Marked High Throughput COVID-19 Diagnostic Assay for Use On Its Automated Amplitude Platform Applied Biosystems TaqPath COVID-19 High Throughput Combo Kit also receives Interim Order Authorization from Health Canada CARLSBAD, Calif., Feb. 8, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today launched its CE-IVD-Marked, Applied Biosystems TaqPath... Read more

February 3, 2021 Clinical Research/Diagn. Lab Top-10 Licensing, IP, and Legal M&A, Partnerships

Thermo Fisher Scientific and JW Therapeutics Announce CAR-T Partnership in China

Companies join forces in cell therapy applications and commercial-scale manufacturing WALTHAM, Mass., Feb. 3, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, has signed an agreement with JW Therapeutics, a leading cell therapy company, to ensure non-exclusive commercial access to Thermo Fisher’s Gibco CTS Dynabeads CD3/CD28. The agreement will support the clinical... Read more

January 28, 2021 Clinical Research/Diagn. M&A, Partnerships

Bio-Techne Announces Strategic Investment in Eminence

MINNEAPOLIS, Jan. 28, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced an initial minority strategic equity investment in Changzhou Eminence Biotechnology Co., Ltd. (“Eminence”).  Eminence will use the financing proceeds to expand its manufacturing capacity and increase the... Read more

January 28, 2021 Atomic Spectroscopy Clinical Research/Diagn. Lab Top-10 M&A, Partnerships Mass Spectrometry

Changi General Hospital and Shimadzu (Asia Pacific) jointly launch centre to conduct mass spectrometry-based clinical testing and research for personalised treatment

Changi General Hospital and Shimadzu (Asia Pacific) jointly launch centre to conduct mass spectrometry-based clinical testing and research for personalised treatment The Shimadzu-CGH Clinomics Centre (SC3) will improve turn-around time and clinical diagnostic accuracy of diseases such as hypertension and other endocrine conditions in adults SINGAPORE, 27 January 2021 – The Shimadzu-CGH Clinomics Centre (SC3),... Read more

January 26, 2021 Clinical Research/Diagn. Life Science Tools Product Launch

PerkinElmer Launches Industry-First GPCR TR-FRET Binding Assay and Beta-Arrestin Kits to Help Advance Therapeutics Discovery

New offerings join PerkinElmer’s leading GPCR Portfolio across characterization and screening assays, screening libraries and workflow optimization WALTHAM, Mass. – January 26, 2021 –PerkinElmer, a global leader committed to innovating for a healthier world, today announced the addition of new assay kits to help further GPCR (G Protein-Coupled Receptor) therapeutic discovery. The new PerkinElmer offerings extend the... Read more

January 26, 2021 Clinical Research/Diagn. Life Science Tools Product Launch

LGC launches SARS-CoV-2 molecular solution for Oral Fluid Testing

LGC has expanded its innovative portfolio of SARS-CoV-2 quality solutions with the release of AccuPlex™ SARS-CoV-2 in Synthetic Oral Fluid reference material. The product is designed to support development and testing efforts around novel saliva-based SARS-CoV-2 diagnostics.  It serves as an ideal research tool for assay developers as well as a complete quality solution for clinical laboratories... Read more